Jonathan Z Li Selected Research

COVID-19 breakthrough infections

1/2023

Anamnestic humoral correlates of immunity across SARS-CoV-2 variants of concern.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonathan Z Li Research Topics

Disease

64	COVID-19 05/2024 - 10/2020
25	Viremia 02/2024 - 09/2012
15	Infections 01/2024 - 09/2014
10	Acquired Immunodeficiency Syndrome (AIDS) 02/2024 - 04/2005
8	Inflammation (Inflammations) 02/2024 - 01/2015
6	HIV Infections (HIV Infection) 02/2024 - 11/2015
4	Neoplasms (Cancer) 03/2024 - 01/2017
3	Virus Diseases (Viral Diseases) 04/2024 - 09/2023
3	Human Influenza (Influenza) 02/2024 - 12/2020
3	Hematologic Neoplasms (Hematological Malignancy) 01/2024 - 01/2017
2	Disease Progression 05/2024 - 04/2011
2	Critical Illness (Critically Ill) 02/2024 - 10/2021
2	Weight Loss (Weight Reduction) 01/2023 - 01/2023
2	Breakthrough Infections 10/2022 - 03/2022
2	Pneumonia (Pneumonitis) 01/2021 - 09/2007
1	Surgical Wound Infection 03/2024
1	Ventral Hernia 03/2024
1	Maternal Obesity 02/2024
1	Fetal Death 02/2024
1	Respiratory Insufficiency (Respiratory Failure) 09/2023
1	Hypoxia (Hypoxemia) 09/2023
1	Vomiting 01/2023
1	Nausea 01/2023
1	COVID-19 breakthrough infections 01/2023
1	Gastroesophageal Reflux (GERD) 01/2023
1	Chronic Disease (Chronic Diseases) 01/2023
1	Postoperative Nausea and Vomiting (PONV) 01/2023
1	Post-Acute COVID-19 Syndrome 01/2023
1	Atherosclerosis 12/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2022
1	Urinary Retention 01/2022
1	Postoperative Pain 01/2022
1	Inguinal Hernia (Direct Inguinal Hernia) 01/2022

Drug/Important Bio-Agent (IBA)

23	RNA (Ribonucleic Acid)IBA 10/2023 - 04/2011
14	Monoclonal AntibodiesIBA 05/2024 - 12/2021
14	Antiviral Agents (Antivirals)IBA 05/2024 - 01/2021
9	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 12/2012
8	AntibodiesIBA 10/2023 - 11/2020
6	CytokinesIBA 02/2024 - 01/2021
6	bamlanivimabIBA 01/2023 - 09/2021
5	InterferonsIBA 02/2024 - 11/2014
5	Viral RNAIBA 01/2024 - 01/2021
5	nirmatrelvir and ritonavir drug combinationIBA 11/2023 - 08/2022
5	VaccinesIBA 01/2023 - 04/2011
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2021
4	Neutralizing AntibodiesIBA 10/2022 - 11/2020
4	Nucleic AcidsIBA 12/2021 - 09/2020
3	AntigensIBA 10/2023 - 12/2021
3	Interleukin-10 (Interleukin 10)IBA 12/2022 - 03/2021
3	N-(2-cyanoethylene)urea (BA 1)IBA 10/2022 - 01/2022
2	amubarvimabIBA 05/2024 - 01/2023
2	romlusevimabIBA 05/2024 - 01/2023
2	Immunologic Factors (Immunomodulators)IBA 02/2024 - 01/2021
2	Immunoglobulin G (IgG)IBA 10/2023 - 01/2023
2	Immunoglobulins (Immunoglobulin)IBA 10/2023 - 01/2023
2	AmphiregulinIBA 11/2022 - 01/2021
2	N-methyl-valyl-amiclenomycin (BA 2)IBA 10/2022 - 03/2022
2	Fluspirilene (Imap)IBA 01/2022 - 01/2021
2	Serine Proteases (Serine Protease)IBA 12/2021 - 12/2020
2	Angiotensin-Converting Enzyme 2IBA 12/2021 - 12/2020
2	Proteins (Proteins, Gene)FDA Link 10/2021 - 11/2020
2	Fc Receptors (Fc Receptor)IBA 10/2021 - 03/2021
2	Interferon LambdaIBA 03/2021 - 01/2021
2	FurinIBA 02/2021 - 01/2021
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 12/2020
1	Prostaglandins AIBA 03/2024
1	cemiplimabIBA 03/2024
1	Interleukin-27 (Interleukin 27)IBA 02/2024
1	crexavibartIBA 01/2024
1	ogalvibartIBA 01/2024
1	Immunoglobulin A (IgA)IBA 10/2023
1	Immunoglobulin M (IgM)IBA 10/2023
1	camostatIBA 10/2023
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2023
1	AcidsIBA 01/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023
1	cilgavimabIBA 01/2023
1	tixagevimabIBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	SAB-185IBA 01/2023
1	Viral AntigensIBA 01/2023
1	Interleukin-7 (Interleukin 7)IBA 01/2023
1	CalciumIBA 12/2022
1	Granzymes (Granzyme)IBA 01/2022
1	Narcotics (Narcotic Analgesics)IBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022

Therapy/Procedure

23	Therapeutics 04/2024 - 09/2012
15	Art Therapy 02/2024 - 01/2014
3	Artificial Respiration (Mechanical Ventilation) 02/2021 - 01/2021
2	Length of Stay 03/2024 - 01/2023
2	Aftercare (After-Treatment) 02/2024 - 01/2023
2	Highly Active Antiretroviral Therapy (HAART) 03/2023 - 02/2011
2	Withholding Treatment 01/2023 - 01/2020
2	Bariatric Surgery 01/2023 - 01/2023
2	Duration of Therapy 12/2022 - 09/2014
1	Intravenous Administration 01/2024
1	Gastrectomy 01/2023
1	Investigational Therapies (Experimental Therapy) 11/2022
1	Urinary Catheters 01/2022